IPHA

Innate Pharma
IPHA

4 hedge funds and large institutions have $5.71M invested in Innate Pharma in 2020 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$14.6K

Top Sellers

1
-$960K
2
-$89.7K
3
-$73.6K
4
Osaic Holdings
Osaic Holdings
Arizona
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.46M
2
$224K
3
$21K
4
$4K
5
–
6
–